Skip to main content
  • MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints

    Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM™ Subcutaneous Implantable Defibrillator and EMPOWER™ Leadless Pacemaker

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details